medigraphic.com
Academia Mexicana de Neurología, A.C.

2011, Number 5

<< Back Next >>

Rev Mex Neuroci 2011; 12 (5)

Kearns-Sayre Syndrome: Case report and literatura review

Méndez-Herrera CR

Language: Spanish
References: 23
Page: 262-265
PDF size: 146.83 Kb.


ABSTRACT

Kearns-Sayre syndrome is a rare mitochondrial disease characterized by chronic progressive external ophthalmoplegia and pigmentary retinopathy with onset before age 20. It is associated with a heterogeneous group of clinical manifestations, among which heart conduction disturbances, muscle weakness, peripheral neuropathy, diabetes mellitus, short stature syndrome and sensorineural deafness are included.


REFERENCES

  1. Bertini E, D’Amico A. Mitochondrial encephalomyopathies and related syndromes: brief review. Endocr Dev 2009; 14: 38-52.

  2. Di Mauro S. Mitochondrial myopathies. Curr Opin Rheumatol 2006; 18: 636-41.

  3. Kierdaszuk B, Jamrozik Z, Tonska K, Bartnik E, Kaliszewska M, Kaminska A, et al. Mitochondrial cytopathies: clinical, morphological and genetic characteristics. Neurol Neurochir Pol 2009; 43: 216-27.

  4. Falk MJ, Sondheimer N. Mitochondrial genetic diseases. Curr Opin Pediatr 2010; 22: 711-6.

  5. Angelini C, Bello L, Spinazzi M, Ferrati C. Mitochondrial disorders of the nuclear genome. Acta Myol 2009; 28: 16-23.

  6. Lamperti C, Zeviani M. Encephalomyopathies caused by abnormal nuclear- mitochondrial intergenomic cross-talk. Acta Myol 2009; 28: 2-11.

  7. Spinazzola A, Invernizzi F, Carrara F, Lamantea E, Donati A, Dirocco M, et al. Clinical and molecular features of mitochondrial DNA depletion syndromes. J Inherit Metab Dis 2009; 32: 143-58.

  8. Maceluch JA, Niedziela M. The clinical diagnosis and molecular genetics of kearns-sayre syndrome: a complex mitochondrial encephalomyopathy. Pediatr Endocrinol Rev 2006; 4: 117-37.

  9. Carod-Artal FJ, Lopez GE, Solano A, Dahmani Y, Herrero MD, Montoya J. [Mitochondrial DNA deletions in Kearns-Sayre syndrome]. Neurologia 2006; 21: 357-64.

  10. Zago FLA, Shiokawa N. [Kearns-Sayre syndrome: two case reports]. Arq Bras Oftalmol 2009; 72: 95-8.

  11. Kearns TP, Sayre GP. Retinitis Pigmentosa, External Ophthalmoplegia, and Complete Heart Block: Unusual Syndrome with Histologic Study in One of Two Cases. AMA Arch Ophthalmol 1958; 60: 280-9.

  12. Rahman S, Hanna MG. Diagnosis and therapy in neuromuscular disorders: diagnosis and new treatments in mitochondrial diseases. J Neurol Neurosurg Psychiatry 2009; 80: 943-53.

  13. Thajeb P, Dai D, Chiang MF, Shyu WC. Genotype-phenotype correlation of maternally inherited disorders due to mutations in mitochondrial DNA. Taiwan J Obstet Gynecol 2006; 45: 201-7.

  14. Mkaouar-Rebai E, Chamkha I, Kammoun T, Chabchoub I, Aloulou H, Fendri N, et al. A case of Kearns-Sayre syndrome with two novel deletions (9.768 and 7.253 kb) of the mtDNA associated with the common deletion in blood leukocytes, buccal mucosa and hair follicles. Mitochondrion 2010; 10: 449-55.

  15. Yau EK, Chan KY, Au KM, Chow TC, Chan YW. A novel mitochondrial DNA deletion in a Chinese girl with Kearns-Sayre syndrome. Hong Kong Med J 2009; 15: 374-7.

  16. Wabbels B, Ali N, Kunz WS, Roggenkamper P, Kornblum C. [Chronic progressive external ophthalmoplegia and Kearns-Sayre syndrome: interdisciplinary diagnosis and therapy]. Ophthalmologe 2008; 105: 550-6.

  17. Laloi-Michelin M, Virally M, Jardel C, Meas T, Ingster-Moati I, Lombes A, et al. Kearns Sayre syndrome: an unusual form of mitochondrial diabetes. Diabetes Metab 2006; 32: 182-6.

  18. Berio A, Piazzi A. A case of Kearns-Sayre syndrome with autoimmune thyroiditis and complete atrio-ventricular block. Minerva Cardioangiol 2006; 54: 387-91.

  19. Berio A, Oliaro E, Piazzi A. Kearns-Sayre syndrome with corneal dystrophy, hypomagnesemia, GH deficiency, and reduced visual acuity. Panminerva Med 2008; 50: 83-4.

  20. Hernandez-Luis C, Garcia-Moran E, Rubio-Sanz J, Fernandez-Aviles F. [Kearns-Sayre syndrome: recurrent syncope and atrial flutter]. Rev Esp Cardiol 2007; 60: 89-90.

  21. Limongelli G, Tome-Esteban M, Dejthevaporn C, Rahman S, Hanna MG, Elliott PM. Prevalence and natural history of heart disease in adults with primary mitochondrial respiratory chain disease. Eur J Heart Fail 2010; 12: 114-21.

  22. Horvath R, Gorman G, Chinnery PF. How can we treat mitochondrial encephalomyopathies? Approaches to therapy. Neurotherapeutics 2008; 5: 558-68.

  23. Tarnopolsky MA, Raha S. Mitochondrial myopathies: diagnosis, exercise intolerance, and treatment options. Med Sci Sports Exerc 2005; 37: 2086-93.




2020     |     www.medigraphic.com